4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-19-024496
Director bought 1,596 shares at an average $6.12 ($9,771)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krogulski Kenneth Director | 2019-04-01 | Purchase | +382 | $5.99 | $2,288 | 156,682 | D |
| Krogulski Kenneth Director | 2019-04-02 | Purchase | +580 | $6.12 | $3,550 | 157,262 | D |
| Krogulski Kenneth Director | 2019-04-03 | Purchase | +80 | $6.00 | $480 | 157,342 | D |
| Krogulski Kenneth Director | 2019-04-04 | Purchase | +241 | $6.19 | $1,492 | 157,583 | D |
| Krogulski Kenneth Director | 2019-04-05 | Purchase | +183 | $6.32 | $1,157 | 157,766 | D |
| Krogulski Kenneth Director | 2019-04-08 | Purchase | +65 | $5.98 | $389 | 157,831 | D |
| Krogulski Kenneth Director | 2019-04-09 | Purchase | +65 | $6.40 | $416 | 157,896 | D |
| Open-market purchases · 1,596 sh · avg $6.12 · $9,771 | |||||||
Loading xslF345X03/doc4.xml…